Saint Luke's Mid America Heart Institute
Saint Luke's Mid America Heart Institute
Kansas City, Missouri, United States5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation. | cardiovascular disorder, heart disorder, heart failure, heart valve disorder, tricuspid valve disorder, tricuspid valve insufficiency | Not yet recruiting | Not applicable | 2026-10-09 | NCT06458907 | |
| A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy | Symptomatic Genetic Dilated Cardiomyopathy | Recruiting | Phase 2 / Phase 3 | 2026-10-05 | NCT07210723 | |
| A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy | Symptomatic Genetic Dilated Cardiomyopathy (DCM) | Recruiting | Phase 3 | 2026-10-02 | NCT07771465 | |
| TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I) | cardiovascular disorder, heart disorder, heart failure, heart valve disorder, tricuspid valve disorder, tricuspid valve insufficiency | Active, not recruiting | Not applicable | 2026-08-28 | NCT06137807 | |
| Global Paradise System US Post Approval Study | cardiovascular disorder, essential hypertension, hypertensive disorder, vascular disorder | Recruiting | Not stated | 2026-08-12 | NCT06297291 |